136 related articles for article (PubMed ID: 3298409)
1. Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
Anderson MG; Harrison TJ; Alexander GJ; Zuckerman AJ; Murray-Lyon IM
J Hepatol; 1986; 3 Suppl 2():S225-7. PubMed ID: 3298409
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
Anderson MG; Harrison TJ; Alexander G; Zuckerman AJ; Murray-Lyon IM
Gut; 1987 May; 28(5):619-22. PubMed ID: 3297940
[TBL] [Abstract][Full Text] [Related]
3. Effect of 28 consecutive days lymphoblastoid interferon (alpha-IFN) administration on hepatitis B virus related chronic liver disease.
Franco A; Barnaba V; Levrero M; Ruberti G; Van Dyke A; Bonavita MS; Balsano F
J Hepatol; 1986; 3 Suppl 2():S239-43. PubMed ID: 3298412
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
Barbara L; Mazzella G; Baraldini M; Gasbarrini G; Giungi F; Malavolti M; Mastroroberto L; Miglio F; Roda E; Raise E
J Hepatol; 1986; 3 Suppl 2():S235-8. PubMed ID: 3298411
[No Abstract] [Full Text] [Related]
5. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
[TBL] [Abstract][Full Text] [Related]
7. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
[TBL] [Abstract][Full Text] [Related]
8. A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients.
Alexander GJ; Fagan EA; Guarner P; Rolando N; Brahm J; Eddleston AL; Williams R
J Hepatol; 1986; 3 Suppl 2():S183-8. PubMed ID: 3298406
[TBL] [Abstract][Full Text] [Related]
9. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
[TBL] [Abstract][Full Text] [Related]
10. Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon.
Giacchino R; Facco F; Giambartolomei G; Navone C; Timitilli A; Cirillo C; Barigione G; Terragna A
Chemioterapia; 1988 Dec; 7 Suppl 3():20-5. PubMed ID: 3073870
[TBL] [Abstract][Full Text] [Related]
11. Lymphoblastoid and recombinant alpha-A interferon therapy of chronic hepatitis B virus infection. The Royal Free Hospital experience.
Thomas HC; Scully LJ; McDonald JA
J Hepatol; 1986; 3 Suppl 2():S193-7. PubMed ID: 3298407
[TBL] [Abstract][Full Text] [Related]
12. Interferon therapy of chronic hepatitis B virus infection in Chinese.
Lok AS; Lai CL; Wu PC
J Hepatol; 1986; 3 Suppl 2():S209-15. PubMed ID: 3036936
[TBL] [Abstract][Full Text] [Related]
13. Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis.
Schalm SW; Heytink RA; Van Buuren HR; De Man RA
J Hepatol; 1986; 3 Suppl 2():S189-92. PubMed ID: 3598156
[TBL] [Abstract][Full Text] [Related]
14. Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis.
Schalm SW; Heytink RA; Van Buuren HR; De Man RA
J Hepatol; 1986; 3 Suppl 2():S137-41. PubMed ID: 3598154
[TBL] [Abstract][Full Text] [Related]
15. Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication.
Lok AS; Weller IV; Karayiannis P; Brown D; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Liver; 1984 Feb; 4(1):45-9. PubMed ID: 6700383
[TBL] [Abstract][Full Text] [Related]
16. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
Eisenburg J; Caselmann W; Eder M; Pape GR
Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
[No Abstract] [Full Text] [Related]
17. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
[TBL] [Abstract][Full Text] [Related]
18. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
[TBL] [Abstract][Full Text] [Related]
19. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
Pastore G; Santantonio T; Monno L; Milella M; Luchena N; Angarano G
Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
[TBL] [Abstract][Full Text] [Related]
20. A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules.
Carreño V; Porres JC; Mora I; Gutiez J; Quiroga JA; Ramón y Cajal S; Oliva H; Compernolle C; Bartolomé J
Antiviral Res; 1987 Oct; 8(3):125-37. PubMed ID: 3501274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
